Abrams Bison Investments 13F, Q4 2024
Abrams Bison · quarter ending 31 December 2024 · filed 14 February 2025 · SEC CIK 1317588
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q4 2024
Weights are against the whole filed book. Changes are in shares held, against the Q3 2024 filing.
| Company | Ticker | Value | % of book | vs Q3 2024 |
|---|---|---|---|---|
| TD SYNNEX CORPORATION | SNX | $263.65M | 27.2% | unchanged |
| SHARKNINJA INC | $143.61M | 14.8% | unchanged | |
| APPLIED MATLS INC | AMAT | $142.30M | 14.7% | +17% shares |
| HCA HEALTHCARE INC | HCA | $119.16M | 12.3% | -4% shares |
| CAPITAL ONE FINL CORP | COF | $99.50M | 10.3% | -3% shares |
| UNITEDHEALTH GROUP INC | UNH | $91.05M | 9.4% | -3% shares |
| CREDIT ACCEP CORP MICH | CACC | $82.16M | 8.5% | -23% shares |
| SELECTQUOTE INC | SLQT | $29.43M | 3.0% | unchanged |
What changed since Q3 2024
Against the Q3 2024 filing, Abrams Bison Investments opened 0 new positions, added to 1, trimmed 4, left 3 unchanged and exited 2. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0000919574-25-001463, filed by ABRAMS BISON INVESTMENTS, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.